Clinical Trial Update: Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance [Phase 4]

View source ↗

Summary

Phase 4 trial compares morning versus evening dosing of endocrine therapy in breast cancer and reports findings on tolerability and patient compliance. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2026-01-08